Teste de caminhada de seis minutos como preditor de descompensação clínica em pacientes com cirrose
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Lower functional capacity is associated with higher morbidity and mortality in several
patients who have chronic non-communicable diseases such as lung, cardiovascular, and kidney
diseases. The 6-minute walk test (6MWT) is a measure of global functional capacity already
recognized and widely used in clinical studies. The shorter distance achieved on the 6MWT is
associated with higher mortality in patients with liver cirrhosis and also in those in a liver
transplant. The aim of the study was to evaluate whether the impairment of this physical
performance can also be associated with the risk of clinical decompensation in patients with
cirrhosis, a hypothesis not yet tested in these groups of patients. For this, we raised the question
about if the 6MWT has a predictive capacity for clinical decompensation of liver cirrhosis
(appearance of ascites, jaundice, upper gastrointestinal bleeding secondary to rupture of
esophagogastric variceal or spontaneous bacterial peritonitis) after one year. This is a
prospective study involving patients with liver cirrhosis of several etiologies in stable clinical
conditions at the moment of their inclusion in the protocol. The patients were followed up for
12 months after the baseline functional assessment by the 6MWT, aiming to identify the
occurrence of clinical decompensation of cirrhosis in this period. Differences between groups
with and without clinical decompensation were assessed using the independent t-test. The
sensitivity and specificity of the 6MWT were determined using the ROC curve (Receiver
Operating Characteristic), the area under the curve, and its confidence intervals (95% CI). The
cut-off value for the 6MWT that best predicted the appearance of clinical decompensation of
cirrhosis was determined using the Youden index and parameters of efficacy. Kaplan-Meier
curves were performed to assess cumulative survival considering the 6MWT cut-off point and,
to test the difference between these curves was used the adapt the log-rank test. The participants
had a mean age of 56.3 ± 10.5 years, 65% were men, 65.4% were classified as Child-Pug Class
A, and among the etiologies of cirrhosis, alcohol, virus C, and non-alcoholic steatohepatitis
were predominated. The ROC curve determined a DC6M less than 401.8 meters as the cut-off
point to predict the appearance of clinical decompensation in patients with cirrhosis with a
sensitivity of 64% and specificity of 82%. Survival analysis shows that patients who walked
less than 401.8 m during the 6MWT had a decompensation-free survival rate of 30% compared
to a 75% rate for those who walked more than 401.8 m (p <0.01). These results show that
6MWD was predictive of clinical decompensation in patients with liver cirrhosis within one
year of follow-up. A 401.8-meter cut-off point was associated with an increased risk of clinical
decompensation in clinically stable cirrhotic patients at baseline. The 6MWT seems to be useful
to be added to the routine prognostic assessment of this population.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

